Literature DB >> 28402431

Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States.

Lauren Canary1, Susan Hariri1, Cecily Campbell1, Randall Young2, Jeannette Whitcomb3, Harvey Kaufman4, Claudia Vellozzi1.   

Abstract

Using commercial laboratory data, we found 80% of 29382 young persons currently infected with hepatitis C virus lived >10 miles from a syringe services program. The median distance was 37 miles, with greater distances in rural areas and Southern and Midwestern states. Strategies to improve access to preventive services are warranted. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  harm reduction; hepatitis C; infectious disease; rural health; syringe services programs

Mesh：

Year:  2017        PMID： 28402431     DOI： 10.1093/cid/cix333

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  22 in total

1.  Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.

Authors:  Asher J Schranz; Aaron Fleischauer; Vivian H Chu; Li-Tzy Wu; David L Rosen
Journal:  Ann Intern Med       Date:  2018-12-04       Impact factor: 25.391

Review 2.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.

Authors:  Hannah Fraser; Claudia Vellozzi; Thomas J Hoerger; Jennifer L Evans; Alex H Kral; Jennifer Havens; April M Young; Jack Stone; Senad Handanagic; Susan Hariri; Carolina Barbosa; Matthew Hickman; Alyssa Leib; Natasha K Martin; Lina Nerlander; Henry F Raymond; Kimberly Page; Jon Zibbell; John W Ward; Peter Vickerman
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

4.  Opioids, Hepatitis C Virus Infection, and the Missing Vaccine.

Authors:  Kimberly Page; Andrea Cox; Paula J Lum
Journal:  Am J Public Health       Date:  2018-02       Impact factor: 9.308

5.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb
Journal:  AIDS Behav       Date:  2020-06

6.  PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.

Authors:  Susan G Sherman; Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Derrick Hunt; C Patrick Chaulk; Brian W Weir
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

7.  State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.

Authors:  Marcelo H Fernández-Viña; Nadya E Prood; Adam Herpolsheimer; Joshua Waimberg; Scott Burris
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

8.  Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.

Authors:  Kathryn E Lancaster; Hannah L F Cooper; Christopher R Browning; Carlos D Malvestutto; John F P Bridges; April M Young
Journal:  Subst Use Misuse       Date:  2020-08-04       Impact factor: 2.164

Review 9.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

10.  HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.

Authors:  Alberto Edeza; Angela Bazzi; Peter Salhaney; Dea Biancarelli; Ellen Childs; Matthew J Mimiaga; Mari-Lynn Drainoni; Katie Biello
Journal:  Subst Use Misuse       Date:  2019-10-09       Impact factor: 2.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.